Google News – FDA (biotech/pharma) External News
All Articles
Google News – FDA (biotech/pharma) External News
Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication - Fierce Pharma
Google News – FDA (biotech/pharma) External News
FDA issues warning letter to Aurobindo’s subsidiary - The Pharma Letter
Google News – FDA (biotech/pharma) External News
FDA nod is just the first hurdle for Moderna’s potential blockbuster flu vax - Pharma Voice
Google News – FDA (biotech/pharma) External News
Ionis Pharma (IONS): FDA Catalysts, Accelerating Revenue And A Path To 2028 Cash-flow Breakeven - RTTNews
Google News – FDA (biotech/pharma) External News
US FDA Closes Aurolife Pharma Raleigh Plant Inspection With VAI Classification - BW Healthcare World
Google News – FDA (biotech/pharma) External News
Aurobindo Pharma Says US FDA Classifies Unit's Raleigh Plant As Voluntary Action Indicated - TradingView
Google News – FDA (biotech/pharma) External News
NervGen Pharma (NGEN) Advances RESTORE Study with FDA Backing, F - GuruFocus
Google News – FDA (biotech/pharma) External News
Ascelia Pharma Announces FDA Has Scheduled Type A Meeting for Orviglance NDA on September 9, 2026 - marketscreener.com
Google News – FDA (biotech/pharma) External News
Capricor soars on plan to amend DMD filing after adcomm setback - Fierce Biotech
Google News – Digital Health External News
Beyond Access: Rethinking the Digital Health Divide - Docwire News
Google News – Digital Health External News
FDA names second participant in TEMPO digital health pilot - MedTech Dive
Google News – Digital Health External News
“How Healthy Am I?” How Health Systems Are Answering the Question Consumers Ask with PatientGPT - beckerscardiology.com
Google News – Digital Health External News
The Rise of Consumer Diagnostics and Emerging Trends - MedCity News
Google News – Digital Health External News